Related Experiment Videos

Production of the effector molecule thymidine by human lung alveolar macrophages

Insights

Human alveolar macrophages secrete thymidine, inhibiting tumor cell growth. This occurs via de novo synthesis and dephosphorylation due to a lack of thymidine kinase, potentially modulating the tumor microenvironment.

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Cultured human alveolar macrophages (HAM phi) produce soluble factors that inhibit tumor cell proliferation.
  • Thymidine (TdR) is implicated as a potential inhibitory factor secreted by macrophages.

Purpose of the Study:

  • To investigate the production and mechanism of thymidine secretion by cultured human alveolar macrophages.
  • To determine if thymidine secretion by HAM phi influences tumor cell growth in vitro.

Main Methods:

  • Detection of thymidine in macrophage culture supernatants using thin-layer chromatography.
  • Tracing the de novo synthesis of thymidine using radiolabeled precursors ([6-14C]-orotic acid and [3H]-TMP).
  • Analysis of nucleotide metabolism and dephosphorylation pathways via high-pressure liquid chromatography.

Main Results:

  • Cultured human alveolar macrophages actively secrete thymidine into their supernatant.
  • Macrophages convert orotic acid and TMP into labeled thymidine, indicating de novo synthesis and dephosphorylation.
  • The absence of thymidine kinase in mature macrophages explains the accumulation and secretion of thymidine.

Conclusions:

  • Human alveolar macrophages synthesize and secrete thymidine, a process facilitated by their lack of thymidine kinase.
  • Secreted thymidine can inhibit tumor cell DNA synthesis through the 'thymidine blockade' phenomenon.
  • This macrophage-mediated thymidine secretion may represent a localized mechanism for modulating tumor cell growth within the immediate microenvironment.

Related Concept Videos